+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiopulmonary Support System Market by Component, Disease Type, Patient Type, Application, End Use - Global Forecast to 2030- Product Image
Cardiopulmonary Support System Market by Component, Disease Type, Patient Type, Application, End Use - Global Forecast to 2030- Product Image
Sale

Cardiopulmonary Support System Market by Component, Disease Type, Patient Type, Application, End Use - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055082
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiopulmonary support system market is evolving rapidly as healthcare organizations worldwide face rising demand for life-saving interventions and look to incorporate advanced extracorporeal therapies into everyday practice. Senior leaders need insights into technological shifts, supply chain adaptations, regulatory trends, and competitive strategies to stay ahead in this critical medtech segment.

Market Snapshot: Cardiopulmonary Support System Market Overview

The Cardiopulmonary Support System Market grew from USD 2.65 billion in 2024 to USD 2.86 billion in 2025. It is expected to continue growing at a CAGR of 7.82%, reaching USD 4.17 billion by 2030. Market momentum is shaped by heightened clinical awareness, increasing incidence of acute and chronic cardiovascular diseases, and continual innovation in circulatory and oxygenation devices across both established and emerging economies.

Scope & Segmentation

This comprehensive report examines the full spectrum of the cardiopulmonary support system market, detailing the technologies, clinical applications, disease areas, and regional footprints that guide procurement and operational decisions.

  • Components: Cardiopulmonary bypass equipment, extracorporeal membrane oxygenation devices, intra-aortic balloon pumps, and ventricular assist devices form the technical backbone for diverse patient needs.
  • Disease Types: Covers solutions for adult respiratory distress syndrome, cardiogenic shock, and pulmonary edema, supporting care for acute and chronic conditions.
  • Patient Demographics: Includes adult, geriatric, and pediatric patients—each segment requiring tailored clinical interfaces and care protocols.
  • Applications: Spans cardiac surgery, cardiology, emergency medicine, and intensive care, accommodating varied institutional requirements.
  • End Uses: Provides insights for ambulatory surgical centers, hospitals, and specialty clinics with different procurement and operational models.
  • Regional Analysis: Explores major geographies within the Americas; Europe, Middle East & Africa; and Asia-Pacific, reflecting local investment trends and care infrastructure differences.
  • Leading Companies: Profiles top device manufacturers and innovators active in system development, AI-driven analytics, membrane manufacturing, and clinical integration across global markets.

Key Takeaways for Senior Decision-Makers

  • Digital integration and real-time analytics continue to transform monitoring, enabling more personalized, responsive therapy for critically ill patients in a range of settings.
  • Manufacturers are prioritizing R&D in portable, minimally invasive, and biocompatible systems to better serve both acute episodes and long-term care management.
  • Emerging contract models now incentivize value-based care, rewarding healthcare providers not only for device adoption but for measurable improvements in outcomes and efficiency.
  • Rapid regional market growth is seen in Asia-Pacific, supported by investment in new hospitals and rising demand for adaptable, affordable technology platforms.
  • Strategic alliances between leading companies, research bodies, and data analytics firms foster innovation and accelerate clinical adoption of next-generation support systems.
  • Healthcare buyers are increasingly focused on supply chain resilience, adopting diversified sourcing and inventory management strategies to address cost and availability risks.

Tariff Impact in 2025: Navigating Financial and Operational Challenges

Recent tariff changes have affected sourcing costs and production processes for various components and finished devices. Manufacturers are responding by localizing operations, renegotiating agreements, and forming new partnerships to strengthen supply chains. Healthcare providers are also consolidating purchasing power to offset increased acquisition costs, and organizations are adapting by building more resilient and flexible procurement systems. These cost pressures also encourage ongoing innovation in component design and sourcing strategies to reduce future policy risk.

Methodology & Data Sources

This report leverages robust primary and secondary research, including in-depth interviews with clinicians, procurement leaders, and device manufacturers. Data triangulation and panel validation align quantitative evidence with qualitative insights. Sources include industry reports, regulatory filings, patent databases, and peer expert review.

Why This Report Matters for Decision-Makers

  • Identifies actionable trends and best practices for integrating advanced cardiopulmonary support into existing care structures, helping to future-proof strategic investments.
  • Provides clarity on the roles of new technologies, regional demand shifts, and regulatory transitions, supporting informed procurement, partnership, and development choices.
  • Equips organizations to assess risk, align operational models with evolving care standards, and pinpoint optimal strategies for market entry or expansion.

Conclusion

Forward-thinking organizations will position themselves for sustained growth by investing in new technologies, strengthening supply chains, and pursuing collaborative innovation. This report serves as a critical tool for senior leaders shaping the future of critical care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiopulmonary Support System Market, by Component
8.1. Introduction
8.2. Cardiopulmonary Bypass Equipment
8.3. Extracorporeal Membrane Oxygenation
8.4. Intra-Aortic Balloon Pumps
8.5. Ventricular Assist Devices
9. Cardiopulmonary Support System Market, by Disease Type
9.1. Introduction
9.2. Adult Respiratory Distress Syndrome
9.3. Cardiogenic Shock
9.4. Pulmonary Edema
10. Cardiopulmonary Support System Market, by Patient Type
10.1. Introduction
10.2. Adult Patients
10.3. Geriatric
10.3.1. Patients
10.4. Pediatric Patients
11. Cardiopulmonary Support System Market, by Application
11.1. Introduction
11.2. Cardiac Surgery
11.3. Cardiology
11.4. Emergency Medicine
11.5. Intensive Care
12. Cardiopulmonary Support System Market, by End Use
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
12.4. Specialty Clinics
13. Americas Cardiopulmonary Support System Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiopulmonary Support System Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiopulmonary Support System Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Baxter International
16.3.3. BIOTRONIK SE & Co KG
16.3.4. Boston Scientific Corporation
16.3.5. Concordia Laboratories Inc.
16.3.6. Edwards Lifesciences Corporation
16.3.7. Eurosets S.r.l
16.3.8. Fresenius Medical Care AG
16.3.9. General Electric Company
16.3.10. Getinge AB
16.3.11. Jarvik Heart, Inc.
16.3.12. Johnson & Johnson
16.3.13. LivaNova PLC
16.3.14. Medtronic PLC
16.3.15. MicroPort Scientific Corporation
16.3.16. Nipro Corporation
16.3.17. Penumbra, Inc.
16.3.18. Senko Medical Instrument Manufacturing Co., Ltd.
16.3.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.3.20. Siemens AG
16.3.21. Spectrum Medical
16.3.22. Stryker Corporation
16.3.23. SynCardia Systems, LLC
16.3.24. Terumo Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. CARDIOPULMONARY SUPPORT SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOPULMONARY SUPPORT SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOPULMONARY SUPPORT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTRA-AORTIC BALLOON PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PULMONARY EDEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 48. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 81. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 85. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 91. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 99. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 103. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 105. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 109. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 133. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 145. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 147. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 151. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 166. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 169. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 171. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 175. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 184. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 187. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 189. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 193. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 209. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 210. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 212. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 214. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 217. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 218. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 220. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 222. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 224. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 248. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY GERIATRIC, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN CARDIOPULMONARY SUPPORT SYSTEM MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 280. CARDIOPULMONARY SUPPORT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
TABLE 281. CARDIOPULMONARY SUPPORT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiopulmonary Support System market report include:
  • Abbott Laboratories
  • Baxter International
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Concordia Laboratories Inc.
  • Edwards Lifesciences Corporation
  • Eurosets S.r.l
  • Fresenius Medical Care AG
  • General Electric Company
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Penumbra, Inc.
  • Senko Medical Instrument Manufacturing Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Spectrum Medical
  • Stryker Corporation
  • SynCardia Systems, LLC
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.17 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Blood Pump for Cardiopulmonary Bypass Market by End User, Application, Power Source, Pump Type, Flow Rate, Technology - Global Forecast to 2030 - Product Image

Blood Pump for Cardiopulmonary Bypass Market by End User, Application, Power Source, Pump Type, Flow Rate, Technology - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Cardiopulmonary Stress Testing System Market by Product Type, End User, Application, Technology - Global Forecast to 2030 - Product Image

Cardiopulmonary Stress Testing System Market by Product Type, End User, Application, Technology - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Perfusion Systems - Global Strategic Business Report - Product Image

Perfusion Systems - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cardiopulmonary Stress Testing Systems - Global Strategic Business Report - Product Image

Cardiopulmonary Stress Testing Systems - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Cardiopulmonary Stress Testing System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cardiopulmonary Stress Testing System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.